3-Aminobenzamine is an inhibitor of poly(ADP)-ribosyl polymerase (PARP) that exhibits cytoprotective, anti-atherosclerotic, and anticancer activities. 3-Aminobenzamide prevents UV-induced cell death in vitro and inhibits TGF-?1-induced phosphorylation of Smad3 in other cellular models. In vivo, this compound inhibits production of inflammatory cytokines, suppresses PARP activation, and decreases atherosclerotic lesion size. Additionally, 3-aminobenzamide induces G1 phase cell cycle arrest, downregulates expression of cyclin D1, ?-catenin, c-Jun, c-Myc, and Id2, upregulates expression of p21 and genes involved in differentiation, and induces differentiation in osteosarcoma cells.
Popular test
Uniformity of Dosage Units
Allschoolabs
Uniformity of Dosage Units is a specialised analytical laboratory service that assesses whether individual dosage units contain sufficiently consis...
![ANTI D TITRE – [Serum]](https://app.analysisafrica.com/backend/uploads/tests/images/1754385122_6891cae238432.jpg)
No products in the cart.